Dynamic Connectivity Under Metabolic Constraints
NCT04840095 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2023-01-12
Summary
In this study, we investigate the impact of insulin resistance on the acceleration of brain aging, and test whether increased neuron insulin resistance can be counteracted by utilization of alternate metabolic pathways (e.g., ketones rather than glucose). This study has three Arms, which together provide synergistic data. For all three Arms, subjects are tested in a within-subjects design that consists of 2-3 testing sessions, 1-14 days apart, and counter-balanced for order. During each session we measure the impact of fuel (glucose in one session, ketones in the other) on brain metabolism and associated functioning. For Arms 1-2, our primary experimental measure is functional magnetic resonance imaging (fMRI), which we will use to trace the self-organization of functional networks following changes in energy supply and demand. Arm 1 tests the impact of endogenous ketones produced by switching to a low carbohydrate diet, while Arm 2 tests the impact of exogenous ketones consumed as a nutritional supplement. For Arm 3, we use simultaneous magnetic resonance spectroscopy/positron-emission tomography (MR/PET) to quantify the impact of exogenous ketones on production of glutamate and GABA, key neurotransmitters.
Subjects will be given the option to participate in more than one of the Arms, but doing so is not expected nor required.
Prior to scans, subjects will receive a clinician-administered History and Physical (H\&P), which includes vital signs, an oral glucose tolerance test (OGTT), and the comprehensive metabolic blood panel. These will be used to assess diabetes, kidney disease, and electrolytes. If subjects pass screening, they will be provided the option to participate in one or more Arms, which include neuroimaging. To provide a quantitative measure of time-varying metabolic activity throughout the scan, based upon quantitative models of glucose and ketone regulation, as well as to be able to implement safety stopping rules (see below), we will obtain pin-prick blood samples three times: prior to the scan, following consumption of the glucose or ketone drink, and following completion of the scan. To assess effects of increased metabolic demand, we measure brain response to cognitive load, transitioning from resting-state to spatial reasoning through a Tetris task. To assess effects of increased metabolic supply, we measure brain response to glucose or ketone bolus.
Conditions
- Insulin Resistance
- Healthy
- Diet Modification
- Aging
Interventions
- DRUG
-
Ketones
Sports supplement that is administered mid-scan.
- DRUG
-
Glucose
Supplement is administered mid-scan.
Sponsors & Collaborators
-
Martinos Center for Biomedical Imaging
collaborator OTHER -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Lilianne Mujica-Parodi, PhD · Stony Brook University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-06-19
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Supplementing Neuro-Energy to Aid Cognition
NCT06767124 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Metabolic Imaging of Neurological Disease
NCT06900244 ·Status: ENROLLING_BY_INVITATION
-
MRI of Glymphatic Clearance During Anesthetic Sedation
NCT02768688 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
NCT05288842 ·Status: RECRUITING
-
Evaluating the Remote Effects of Stroke With MRI and PET Scans
NCT00063180 ·Status: COMPLETED
-
1-hour Post-load Hyperglycemia and Mild Cognitive Impairment
NCT03363516 ·Status: UNKNOWN
-
PET Study of Cerebral Metabolism of 11C-acetoacetate and 18F-FDG in Patients Under Moderate Ketosis
NCT02409784 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging in Metabolic Diseases
NCT06709846 ·Status: RECRUITING
-
Proof of Mechanism of a New Ketogenic Supplement Using Dual Tracer PET (Positron Emission Tomography)
NCT02551419 ·Status: COMPLETED ·Phase: NA
-
IGF and Other Neurotrophic Factors in Patients With Dementia
NCT02271750 ·Status: COMPLETED
-
Quantitative Imaging of Brain Glymphatic Function in Humans
NCT04768101 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Functional MRI Biomarkers of Cognitive Decrements in Diabetes
NCT01705210 ·Status: COMPLETED
-
Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease
NCT04174287 ·Status: UNKNOWN ·Phase: PHASE2
-
Myotonic Dystrophy - Vascular and Cognition
NCT04656210 ·Status: ACTIVE_NOT_RECRUITING
-
Brain Clock and Insulin Resistance
NCT05314855 ·Status: COMPLETED
-
Simultaneously PET/MRI in Prolonged DOC Patients
NCT04164680 ·Status: COMPLETED
-
Technical Development of Multi-Parametric Renocerebral MRI
NCT02831335 ·Status: RECRUITING
-
Interest of Real Time Measurement of Autonomous Nervous System for the Detection of Brain Death
NCT00918970 ·Status: TERMINATED
-
Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444
NCT05009199 ·Status: COMPLETED ·Phase: PHASE1
-
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
NCT00966017 ·Status: UNKNOWN
-
4D FLOW: Feasibility Study of a Sequence 4D of Flow Applied to the Cervico-encephalic Vascular Pathologies
NCT02602951 ·Status: COMPLETED ·Phase: NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
NCT06103201 ·Status: RECRUITING ·Phase: PHASE1
-
Image Detection of Impaired Microcirculatory Reperfusion
NCT07099599 ·Status: RECRUITING
-
Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) Metastases
NCT04700748 ·Status: UNKNOWN ·Phase: NA
-
Evaluating Raised Intracranial Pressure Using MR Elastography
NCT03096743 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA